Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)

NCT02580032 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT02580032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02580032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
October 5, 2015
Completion date
May 14, 2018
Enrollment
252 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

growth disorder, growth hormone deficiency in children